Hospitalisation course and outcome in patients with ESBL producing Enterobacteriaceae infection is considered less favourable due to extensive antibacterial drug resistance (Kim et al., 2002; Peralta et al., 2012) . In order to choose the best empirical antibiotic therapy, physicians should look for factors that could indicate a less favourable hospitalisation course and outcome. An unfavourable hospitalisation course and outcome in patients with ESBL producing Enterobacteriaceae infection previously have been associated with severe concomitant diseases, prior administration of multiple antimicrobial agents, recent surgery, older age and presence of indwelling catheters (Skippen et al., 2006; Mehrgan et al., 2010) .
The aim of this study was to identify additional possible risk factors that could influence the hospitalisation course and outcome in patients with ESBL producing Enterobacteriaceae infection. A cross-sectional single-centre study was conducted in Rîga East Clinical University Hospital. All consecutive ESBL producing Enterobacteriaceae infection cases were selected during a 6-month period (2014). A total of 136 ESBL producing Enterobacteriaceae infection cases were included in the study. Demographic, hospitalisation and clinical data were obtained from medical records on the day patient was discharged. Disease data were encoded according to the International Statistical Classification of Diseases (ICD-10) (Anonymous, 2015) . Biomaterial (urine, bronchoalveolar washing, cerebrospinal fluid, wound swab, sputum, blood, abdominal cavity fluid, abscess sample) for bacteriological analysis was collected in transport medium PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES. Section B, Vol. 70 (2016), No. 4 (703) and transported to the microbiological laboratory within 24 hours. In the laboratory, each sample was cultured. Identification of the bacteria was conducted by a Vitex 2 Compact system (bioMerieux, France) and susceptibility tests by the disk diffusion method (Oxoid, UK; CLSI 2013). ESBL production was confirmed using synergy tests with ESBL and Amp-C inhibiting discs (Rosco, Denmark). Genetic analysis provided information about CTX-M, TEM and SHV bacterial gene presence in the ESBL producing Enterobacteriaceae plasmid genome. Bacteria selected from ESBL producing Enterobacteriaceae colonies were grown in 2 ml Lysogenic broth media at 37°C overnight. Plasmid DNA were isolated by manufacturer protocol using a E.Z.N.A. plasmid Mini Kit I (Omega Bio-Tek, USA). CTX-M, SHV and TEM bacterial plasmid gene detection was performed using polymerase chain reaction (PCR) using gene specific primers (Wu et al., 2001; Edelstein et al., 2003; Anonymous, 2013) . CTX-M gene detection was conducted according to Edelstein et al., 2003 , SHV gene detection according to Nüesch-Inderbinen et al. (1996) , and TEM gene detection according to Du et al. (2013) . PCR products were analysed using 2% agarose gel. A study protocol with 106 parameters was completed for each ESBL-producing Enterobacteriaceae infection case and used for database development and statistical analysis. All p values were two-tailed and considered significant at the 5% level. The study was conducted according to the Helsinki Declaration, reviewed and approved by the local Ethics Committee.
ESBL producing Enterobacteriaceae were isolated from 52 (38.2%) female and 84 (61.8%) male patients at the mean age of 61.35 ± 16.92 (CI 95% 57.76-64.78) years. Mostly ESBL producing K. pneumoniae (n = 66, 48.53%) and E. coli (n = 36, 26.47%) were isolated ( Fig. 1) , mainly from wound (n = 44, 32.35%) biomaterial (Fig. 2) , in most of the cases (n = 132, 97.06%) containing CTX-M gene (Fig. 3) . Patients with ESBL producing Enterobacteriaceae infection aged < 65 years (p = 0.045) and concomitant infectious diseases (p = 0.047) were more frequently admitted to the ICU. Patients with ESBL producing Enterobacteriaceae infection admitted to the ICU (p = 0.02) and suffering from musculoskeletal diseases (p = 0.002) had increased mortality.
A less favourable hospitalisation course and outcome was observed in this study comparing to other literature sources: mean hospital stay was almost three times longer (60 vs 24 days) (Wu et al., 2014) , patients were at least three times more often admitted to the ICU (60% vs 4-23%) (Concepts et al., 2010) , stayed there almost two times longer (19 vs 12 days) (Abdalla et al., 2014) and had a higher mortality rate (21% vs 14%) (Peralta et al., 2012) . This could be explained by the critically ill and immunocompromised patient predominance in the studied patient profile, including patients with severe abdominal trauma, head trauma, extremity amputations and extensive bedsores, suggesting a more severe clinical condition. Significantly more patients in this study presented with shock (13% vs 6%) (Peralta et al., 2012) and were older (70 years) than patients described in the other literature sources (65 years) (Peralta et al., 2012) .
Musculoskeletal disease presence, hospitalisation in internal medicine profile departments, and TEM bacterial gene presence were associated with increased mortality in this study and could be considered as possible risk factors for less favourable hospitalisation course and outcome for patients with ESBL producing Enterobacteriaceae infection. These factors have not been studied as possible risk factors in any studies previously. The CTM-X bacterial gene has been associated with increased mortality in patients with ESBL producing Enterobacteriaceae infection in other studies (Mehrgan et al., 2010) ; however, this association was not observed in our study. Concomitant infectious diseases and age less than 65 years predisposed patients with ESBL producing Enterobacteriaceae infection for more frequent admission to the ICU in this study. Admission to the ICU has been identified as a risk factor for increased mortality also in other studies (Mayr et al., 2006; Du et al., 2013) . Therefore, infectious diseases and younger age might be considered as risk factors for a less favourable hospitalisation course and outcome for patients with ESBL producing Enterobacteriaceae infection.
The study includes preliminary data only and further studies should be carried out to verify the suggested risk factors.
